Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Anemia

  Free Subscription


Articles published in Transfusion

Retrieve available abstracts of 84 articles:
HTML format



Single Articles


    November 2022
  1. MAISONNEUVE E, Sohier Lepine M, Maurice P, Pissard S, et al
    Prenatal management of fetal anemia due to pyruvate kinase deficiency: A case report.
    Transfusion. 2022 Nov 8. doi: 10.1111/trf.17177.
    PubMed     Abstract available


    October 2022
  2. TEAWTRAKUL N, Songdej D, Hantaweepant C, Tantiworawit A, et al
    Red blood cell alloimmunization and other transfusion-related complications in patients with transfusion-dependent thalassemia: A multi-center study in Thailand.
    Transfusion. 2022;62:2039-2047.
    PubMed     Abstract available


  3. ANTHON CT, Granholm A, Sivapalan P, Zellweger N, et al
    Prophylactic platelet transfusions versus no prophylaxis in hospitalized patients with thrombocytopenia: A systematic review with meta-analysis.
    Transfusion. 2022;62:2117-2136.
    PubMed    


  4. KRULL A, Thompson T, Strasburg D, DiGuardo M, et al
    How do I warm HPC(A) products to maximize cell viability in the setting of cold agglutinin disease?
    Transfusion. 2022;62:1942-1947.
    PubMed     Abstract available


  5. GERRITSMA JJ, van der Bolt N, van Bruggen R, Ten Brinke A, et al
    Measurement of post-transfusion red blood cell survival kinetics in sickle cell disease and beta-Thalassemia: A biotin label approach.
    Transfusion. 2022;62:1984-1996.
    PubMed     Abstract available


    September 2022
  6. HOPKINS CK, Townsend M, Vassallo RR
    Leukoreduction filters: Still stuck on sickle trait red cells.
    Transfusion. 2022;62:1683-1687.
    PubMed    


  7. LAURIDSEN L, Campbell-Lee SA
    Doing more with less: Patient blood management meets sickle cell disease management.
    Transfusion. 2022;62:1688-1692.
    PubMed    


  8. GEHRIE EA, Petran L, Young PP
    Sickle cell trait results in a high leukoreduction quality control failure rate for whole blood donations.
    Transfusion. 2022;62:1727-1730.
    PubMed     Abstract available


  9. JONES JM, Swett AD, Crowe EP, Lawrence C, et al
    Implementation of national blood conservation recommendations at an adult sickle cell center.
    Transfusion. 2022;62:1763-1771.
    PubMed     Abstract available


    August 2022
  10. SEHEULT JN, Callum J, Delaney M, Drake R, et al
    Rate of D-alloimmunization in trauma does not depend on the number of RhD-positive units transfused: The BEST collaborative study.
    Transfusion. 2022;62 Suppl 1:S185-S192.
    PubMed     Abstract available


  11. COVINGTON ML, Cone-Sullivan JK, Andrzejewski C, Lu W, et al
    Unmasking delayed hemolytic transfusion reactions in patients with sickle-cell disease: Challenges and opportunities for improvement.
    Transfusion. 2022;62:1662-1670.
    PubMed    


    July 2022
  12. BADE NA, Giri U, Wang H, Ershler WB, et al
    Reduced red cell transfusions and hospitalizations in sickle cell patients treated with voxelotor-Experience from a single center.
    Transfusion. 2022;62:1462-1464.
    PubMed    


  13. FUJA C, Kothary V, Carll TC, Singh S, et al
    Hyperhemolysis in a patient with sickle cell disease and recent SARS-CoV-2 infection, with complex auto- and alloantibody work-up, successfully treated with tocilizumab.
    Transfusion. 2022;62:1446-1451.
    PubMed     Abstract available


  14. HANSEN DL, Moller S, Berentsen S, Frederiksen H, et al
    Mortality in cold agglutinin disease shows seasonal pattern.
    Transfusion. 2022;62:1460-1461.
    PubMed    


    June 2022
  15. KRANENBURG FJ, Arbous SM, Caram-Deelder C, Putter H, et al
    Predicting organ functioning with and without blood transfusion in critically ill patients with anemia.
    Transfusion. 2022 Jun 30. doi: 10.1111/trf.16998.
    PubMed     Abstract available


  16. PROCHASKA M, Salcedo J, Berry G, Meltzer D, et al
    Racial differences in red blood cell transfusion in hospitalized patients with anemia.
    Transfusion. 2022 Jun 3. doi: 10.1111/trf.16935.
    PubMed     Abstract available


    May 2022
  17. JOUZIER C, Cherait A, Cony-Makhoul P, Hamel JF, et al
    Red blood cell transfusion burden in myelodysplastic syndromes (MDS) with ring Sideroblasts (RS): A retrospective multicenter study by the Groupe Francophone des Myelodysplasies (GFM).
    Transfusion. 2022;62:961-973.
    PubMed     Abstract available


    April 2022
  18. CARLL T, Mei Z, Aldarweesh F, Wool GD, et al
    Alloimmunization rates in transfused patients receiving anti-CD47 antibody therapy.
    Transfusion. 2022;62:916-918.
    PubMed    


    March 2022
  19. GUINN NR, Fuller M, Murray S, Aronson S, et al
    Treatment through a preoperative anemia clinic is associated with a reduction in perioperative red blood cell transfusion in patients undergoing orthopedic and gynecologic surgery.
    Transfusion. 2022 Mar 11. doi: 10.1111/trf.16847.
    PubMed     Abstract available


  20. MEENAN J, Hall R, Badle S, Chatterjee B, et al
    Tocilizumab in the management of posttransfusion hyperhemolysis syndrome in sickle cell disease: The experience so far.
    Transfusion. 2022;62:546-550.
    PubMed     Abstract available


  21. WADE J, Yee MEM, Easley KA, Pahz S, et al
    Procedural adverse events in pediatric patients with sickle cell disease undergoing chronic automated red cell exchange.
    Transfusion. 2022;62:584-593.
    PubMed     Abstract available


  22. YEE ME, Francis RO, Luban NLC, Easley KA, et al
    Glucose-6-phosphate dehydrogenase deficiency is more prevalent in Duffy-null red blood cell transfusion in sickle cell disease.
    Transfusion. 2022;62:551-555.
    PubMed     Abstract available


  23. SEEBER P, Dobel KU, Isbister JP, Murray K, et al
    Mortality and morbidity in non-transfusable and transfusable patients: A systematic review and meta-analysis.
    Transfusion. 2022;62:685-697.
    PubMed    


    February 2022
  24. SCHIFFER CA
    Commentary on the prescient observations made by Emil J Freireich in Effectiveness of platelet transfusion in leukemia and aplastic anemia (Transfusion 1966; 6: 50-54).
    Transfusion. 2022;62:267-272.
    PubMed    


    January 2022
  25. PATRIQUIN CJ, Pavenski K
    O, wind, if winter comes ... will symptoms be far behind?: Exploring the seasonality (or lack thereof) and management of cold agglutinin disease.
    Transfusion. 2022;62:2-10.
    PubMed    


  26. ROTH A, Fryzek J, Jiang X, Reichert H, et al
    Complement-mediated hemolysis persists year round in patients with cold agglutinin disease.
    Transfusion. 2022;62:51-59.
    PubMed     Abstract available


  27. KRIGSTEIN M, Cromer N
    Navigating the challenges of Bombay phenotype (Oh ) and twin pregnancy; a case report and literature review.
    Transfusion. 2022;62:247-251.
    PubMed     Abstract available


  28. CARR NR, Henry E, Bahr TM, Ohls RK, et al
    Fetomaternal hemorrhage: Evidence from a multihospital healthcare system that up to 40% of severe cases are missed.
    Transfusion. 2022;62:60-70.
    PubMed     Abstract available


    December 2021
  29. LEE ES, Hendrickson JE, Tormey CA
    RBC alloimmunization and daratumumab: Are efforts to eliminate interferences and prevent new antibodies necessary?
    Transfusion. 2021;61:3283-3285.
    PubMed    


  30. KARKI S, Davison TE, Liu B, Bell K, et al
    Visits to general practitioners after iron-related deferrals from blood donation in middle-aged and older Australian blood donors.
    Transfusion. 2021;61:3335-3343.
    PubMed     Abstract available


  31. ARNONI CP, Vendrame T, Muniz J, Cortez A, et al
    RHCE diversity among Brazilian patients with sickle cell disease (SCD) and selected groups of blood donors.
    Transfusion. 2021;61:3473-3482.
    PubMed     Abstract available


    November 2021
  32. DIANA JS, Manceau S, Leblanc T, Magnani A, et al
    A new step in understanding stem cell mobilization in patients with Fanconi anemia: A bridge to gene therapy.
    Transfusion. 2021 Nov 9. doi: 10.1111/trf.16721.
    PubMed     Abstract available


  33. LIOU S, Bakic L, Manakelew B, Guillermo F, et al
    False anemia due to total parenteral nutrition and lipid emulsion contamination.
    Transfusion. 2021 Nov 5. doi: 10.1111/trf.16728.
    PubMed    


  34. HAMILTON CM, Davenport DL, Bernard AC
    Demonstration of a U.S. nationwide reduction in transfusion in general surgery and a review of published transfusion reduction methodologies.
    Transfusion. 2021;61:3119-3128.
    PubMed     Abstract available


  35. YAMAMOTO T, Bikhet MH, Marques MB, Nguyen HQ, et al
    Initial experimental experience of triple-knockout pig red blood cells as potential sources for transfusion in alloimmunized patients with sickle cell disease.
    Transfusion. 2021;61:3104-3118.
    PubMed     Abstract available


    October 2021
  36. KAMESAKI T
    Diagnostic algorithm for classification and characterization of direct antiglobulin test-negative autoimmune hemolytic anemia with 1-year clinical follow-up.
    Transfusion. 2021 Oct 19. doi: 10.1111/trf.16709.
    PubMed     Abstract available


  37. CALLAN MB, Thawley VJ, Marryott KA, Shabro A, et al
    Hemolytic anemia blunts the cytokine response to transfusion of older red blood cells in mice and dogs.
    Transfusion. 2021 Oct 11. doi: 10.1111/trf.16690.
    PubMed     Abstract available


  38. TANG CH, Furnback W, Wang BCM, Tang J, et al
    Relationship between transfusion burden, healthcare resource utilization, and complications in patients with beta-thalassemia in Taiwan: A real-world analysis.
    Transfusion. 2021;61:2906-2917.
    PubMed     Abstract available


  39. LAL A, Wong T, Keel S, Pagano M, et al
    The transfusion management of beta thalassemia in the United States.
    Transfusion. 2021;61:3027-3039.
    PubMed    


  40. ABEL GA, Klepin HD, Magnavita ES, Jaung T, et al
    Peri-transfusion quality-of-life assessment for patients with myelodysplastic syndromes.
    Transfusion. 2021;61:2830-2836.
    PubMed     Abstract available


    September 2021
  41. GADI SRV, Brunker PAR, Al-Samkari H, Sykes DB, et al
    Severe Autoimmune Hemolytic Anemia Following Receipt of SARS-CoV-2 mRNA Vaccine.
    Transfusion. 2021 Sep 22. doi: 10.1111/trf.16672.
    PubMed     Abstract available


  42. ANG AL, Lim CY, Ng WY, Lam JCM, et al
    Non-transfusion dependent thalassemia is independently associated with higher alloimmunization risk than transfusion dependent thalassemia and would benefit the most from extended red cell antigen-matching.
    Transfusion. 2021;61:2566-2577.
    PubMed     Abstract available


  43. AVECILLA ST, Boulad F, Yazdanbakhsh K, Sadelain M, et al
    Process and procedural adjustments to improve CD34+ collection efficiency of hematopoietic progenitor cell collections in sickle cell disease.
    Transfusion. 2021;61:2775-2781.
    PubMed     Abstract available


    August 2021
  44. TANHEHCO YC, Delgado AC
    Red blood cell reduction of a sickle cell disease stem cell product.
    Transfusion. 2021 Aug 29. doi: 10.1111/trf.16633.
    PubMed    


  45. SALINAS CISNEROS G, Webb J, Luban NLC, Nickel RS, et al
    Impact of universal irradiation on chronic transfusion for sickle cell disease.
    Transfusion. 2021;61:2290-2294.
    PubMed     Abstract available


  46. CHIDAMBARAM V, Jones JM, Lokhandwala PM, Bloch EM, et al
    Low rates of transfusion-transmitted infection screening in chronically transfused adults with sickle cell disease.
    Transfusion. 2021;61:2421-2429.
    PubMed     Abstract available


  47. MUNIZ JG, Arnoni C, Medeiros R, Vendrame T, et al
    Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization.
    Transfusion. 2021;61:2458-2467.
    PubMed     Abstract available


  48. RANKIN A, Darbari D, Campbell A, Webb J, et al
    Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease.
    Transfusion. 2021;61:2255-2264.
    PubMed     Abstract available


    July 2021
  49. CAHILL CM, Alhasson B, Blumberg N, Melvin A, et al
    Preoperative anemia management program reduces blood transfusion in elective cardiac surgical patients, improving outcomes and decreasing hospital length of stay.
    Transfusion. 2021 Jul 15. doi: 10.1111/trf.16564.
    PubMed     Abstract available


  50. SARKER TT, Delvadia B, Li S, Roback JD, et al
    Mizuho hemoglobinopathy, presenting with severe hemolytic anemia and multisystem organ failure secondary to exertion.
    Transfusion. 2021 Jul 1. doi: 10.1111/trf.16522.
    PubMed    


  51. HASAN RA, Asif M, Tuott EE, Stansbury LG, et al
    Rates of delayed hemolytic transfusion reactions observed in a trauma center.
    Transfusion. 2021;61:2035-2040.
    PubMed     Abstract available


  52. GOWDA L, Vege S, Kessler D, Shaz B, et al
    Screening of blood donors for sickle cell trait using a DNA-based approach: Frequency in a multiethnic donor population.
    Transfusion. 2021;61:2008-2013.
    PubMed     Abstract available


    June 2021
  53. GAMBERINI MR, Fortini M, Stievano A, Calori E, et al
    Impact of the preparation method of red cell concentrates on transfusion indices in thalassemia patients: A randomized crossover clinical trial.
    Transfusion. 2021;61:1729-1739.
    PubMed     Abstract available


  54. GODBEY EA, Anderson MR, M Bachmann L, Sanford KW, et al
    How do we monitor hemoglobin S in patients who undergo red blood cell exchange and take voxelotor?
    Transfusion. 2021;61:1680-1683.
    PubMed    


  55. BAROUQA M, Szymanski J, Nelson R, Jofre S, et al
    Bone marrow necrosis and fat embolism syndrome in sickle cell disease: A rapidly deteriorating complication.
    Transfusion. 2021;61:1678-1679.
    PubMed    


    May 2021
  56. ANANDAPPA AJ, Stefely JA, Hasserjian RP, Dzik WH, et al
    Multiorgan failure in a fatal case of autoimmune hemolytic anemia.
    Transfusion. 2021 May 27. doi: 10.1111/trf.16513.
    PubMed     Abstract available


  57. LI S, He Z, Mo C, Ji Y, et al
    Hyporegenerative anemia in anti-M-associated hemolytic disease of the fetus.
    Transfusion. 2021 May 3. doi: 10.1111/trf.16350.
    PubMed     Abstract available


  58. MCOMISH C
    A monthly roundup of key articles in other journals.
    Transfusion. 2021;61:1355-1358.
    PubMed    


  59. GUARENTE J, Palladino M, Babariya S, Hayes C, et al
    Iatrogenic arteriovenous fistula in patient with sickle cell disease undergoing red blood cell exchange.
    Transfusion. 2021;61:1361-1362.
    PubMed    


    April 2021
  60. THEMELIN N, Biston P, Massart J, Lelubre C, et al
    Effects of red blood cell transfusion on global oxygenation in anemic critically ill patients.
    Transfusion. 2021;61:1071-1079.
    PubMed     Abstract available


  61. JUSKEWITCH JE, Murray JD, Norgan AP, Moldenhauer SK, et al
    In from the cold: M-protein light chain glycosylation is positively associated with cold agglutinin titer levels.
    Transfusion. 2021;61:1302-1311.
    PubMed     Abstract available


    March 2021
  62. NGUYEN TN, Maenulein E, Fihman V, Vinatier I, et al
    Serologic characteristics of oxaliplatin antibodies in 15 patients with drug-induced immune hemolytic anemia.
    Transfusion. 2021 Mar 9. doi: 10.1111/trf.16360.
    PubMed     Abstract available


  63. ATAGA KI, Elsherif L, Wichlan D, Wogu AF, et al
    A pilot study of the effect of rivaroxaban in sickle cell anemia.
    Transfusion. 2021 Mar 4. doi: 10.1111/trf.16343.
    PubMed     Abstract available


    February 2021
  64. YATES B, Molloy E, Dulau-Florea A, Braylan R, et al
    Daratumumab for delayed RBC engraftment following major ABO mismatched haploidentical bone marrow transplantation.
    Transfusion. 2021 Feb 2. doi: 10.1111/trf.16281.
    PubMed     Abstract available


  65. DURIEUX-ROUSSEL E, Laget L, Filosa L, Izard C, et al
    RHCE*01 (c.499A>G, p.Met167Val) allele: Weak RhE expression which does not require the E-specific proline 226.
    Transfusion. 2021;61:E18-E20.
    PubMed    


  66. ZIEMBA Y, Xu C, Fomani KM, Nandi V, et al
    Safety and benefits of automated red cell depletion-exchange compared to standard exchange in patients with sickle cell disease undergoing chronic transfusion.
    Transfusion. 2021;61:526-536.
    PubMed     Abstract available


  67. DINARDO CL, Oliveira TGM, Kelly S, Ashley-Koch A, et al
    Diversity of variant alleles encoding Kidd, Duffy, and Kell antigens in individuals with sickle cell disease using whole genome sequencing data from the NHLBI TOPMed Program.
    Transfusion. 2021;61:603-616.
    PubMed     Abstract available


  68. SLICHTER SJ, Gernsheimer T, LeBlanc R, Townsend-McCall D, et al
    Fecal blood loss: A quantitative method of evaluating hemostasis in patients with thrombocytopenia.
    Transfusion. 2021;61:393-403.
    PubMed     Abstract available


    January 2021
  69. ANDERSEN LH, Jacob EK, McThenia SS, Tauscher CD, et al
    Hemolytic disease and reticulocytopenia of the newborn attributable to maternal immunoglobulin G anti-M reacting optimally at cold temperatures.
    Transfusion. 2021 Jan 14. doi: 10.1111/trf.16252.
    PubMed     Abstract available


  70. SPENCER BR, Fox MP, Wise LA, Cable RG, et al
    Iron status and self-reported fatigue in blood donors.
    Transfusion. 2021;61:124-133.
    PubMed     Abstract available


  71. JUSKEWITCH JE, Zuccarelli MD, Berg HE, Summerfield DD, et al
    Transfusion medicine illustrated: When less is more for HLA antibodies.
    Transfusion. 2021;61:9-11.
    PubMed    


  72. VASSALLO RR
    Donor iron depletion in context.
    Transfusion. 2021;61:318-321.
    PubMed    


  73. RICHARDS AL, Qiu A, Zotti FD, Sheldon K, et al
    Autoantigen presentation by splenic dendritic cells is required for RBC-specific autoimmunity.
    Transfusion. 2021;61:225-235.
    PubMed     Abstract available


  74. SRIVASTAVA K, Albasri J, Alsuhaibani OM, Aljasem HA, et al
    SCAR: The high-prevalence antigen 013.008 in the Scianna blood group system.
    Transfusion. 2021;61:246-254.
    PubMed     Abstract available


  75. SAYERS M
    Donor iron nutrition: Which precaution prevails?
    Transfusion. 2021;61:313-317.
    PubMed    


    December 2020
  76. JACOBS J, Eichbaum Q
    COVID-19 associated with severe autoimmune hemolytic anemia.
    Transfusion. 2020 Dec 3. doi: 10.1111/trf.16226.
    PubMed     Abstract available


  77. PAGANO MB, Cataife G, Fertrin KY, Gernsheimer T, et al
    Blood use and transfusion needs at a large health care system in Washington state during the SARS-CoV-2 pandemic.
    Transfusion. 2020;60:2859-2866.
    PubMed     Abstract available


    October 2020
  78. BEVERINA I, Scalvini R, Brando B
    "Camel humps"-shaped red blood cell histogram in a woman with extreme anemia treated with intravenous iron.
    Transfusion. 2020 Oct 28. doi: 10.1111/trf.16154.
    PubMed    


  79. GARCIA-GARCIA I, Cid J, Palomino A, Gine E, et al
    Role of therapeutic plasma exchanges in refractory severe warm autoimmune hemolytic anemia: Presentation of two case reports.
    Transfusion. 2020 Oct 22. doi: 10.1111/trf.16143.
    PubMed     Abstract available


  80. STEUER LV, Kondo AT, Cipolletta AN, Sakashita AM, et al
    Predictive factors for the development of anemia after hematopoietic stem cell donation.
    Transfusion. 2020 Oct 14. doi: 10.1111/trf.16124.
    PubMed     Abstract available


  81. MAZZEFFI M, Taneja M, Porter S, Chow JH, et al
    Anemia, sex, and race as predictors of morbidity or mortality after knee arthroplasty surgery.
    Transfusion. 2020 Oct 5. doi: 10.1111/trf.16111.
    PubMed     Abstract available


  82. FERGUSSON DA, Lalu MM
    Mind the evidence gap: The need for trials in the prevention and management of perioperative anemia in noncardiac surgery.
    Transfusion. 2020;60:2168-2170.
    PubMed    


    September 2020
  83. SANCHEZ-DURAN MA, Higueras MT, Aviles-Garcia M, Maiz N, et al
    Perinatal outcomes and central nervous system abnormalities following intrauterine fetal transfusion: 17 years' experience in a tertiary center.
    Transfusion. 2020 Sep 21. doi: 10.1111/trf.16087.
    PubMed     Abstract available


  84. NIZZI F, Rees M, Salzberg D, Ngwube A, et al
    Successful management of sirolimus toxicity in a hematopoietic stem cell transplant patient using automated red blood cell exchange.
    Transfusion. 2020 Sep 5. doi: 10.1111/trf.16064.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: